{
    "eid": "2-s2.0-85165292711",
    "title": "Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "AUC24h/MIC",
        "Cmax/MIC",
        "critically ill",
        "gentamicin",
        "nephrotoxicity"
    ],
    "authors": [
        "Mohammad Yaseen Abbasi",
        "Weerachai Chaijamorn",
        "Taniya Charoensareerat",
        "Thitima Doungngern",
        "Kamonthip Wiwattanawongsa"
    ],
    "citedby-count": 0,
    "ref-count": 57,
    "ref-list": [
        "Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter",
        "Optimizing aminoglycoside use",
        "The effect of pathophysiology on pharmacokinetics in the critically ill patient-concepts appraised by the example of antimicrobial agents",
        "Aminoglycosides in the Intensive Care Unit: what is new in population PK modeling?",
        "Reappraisal of contemporary pharmacokinetic and pharmacodynamic principles for informing aminoglycoside dosing",
        "Pharmacodynamics of tobramycin in patients with cystic fibrosis",
        "Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients",
        "Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper",
        "A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity",
        "Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity",
        "Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients",
        "Pharmacokinetics of once-daily dosing of gentamicin in surgical intensive care unit patients with open fractures",
        "Validation of the Hartford nomogram in trauma surgery patients",
        "Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care",
        "Comparison of aminoglycoside clearance and calculated serum creatinine clearances",
        "Gentamicin pharmacokinetic changes related to mechanical ventilation",
        "Changes in gentamicin pharmacokinetic profiles induced by mechanical ventilation",
        "Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post-operative septic shock patients",
        "Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients",
        "Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose",
        "Factors affecting gentamicin pharmacokinetics in septic patients",
        "Inadequacy of standard aminoglycoside loading doses in acutely ill patients",
        "Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients",
        "Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients",
        "Bayesian forecasting of serum gentamicin concentrations in intensive care patients",
        "Determination of gentamicin pharmacokinetics by bioelectrical impedance in critically ill adults",
        "Experience with a once-daily dosing program of aminoglycosides in critically ill patients",
        "Evaluation of four once-daily aminoglycoside dosing nomograms",
        "Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients",
        "Gentamicin volume of distribution in critically ill septic patients",
        "Altered aminoglycoside pharmacokinetics in the critically ill",
        "Monte Carlo simulation in the evaluation of susceptibility breakpoints: predicting the future: insights from the society of infectious diseases pharmacists",
        "Society of Infectious Diseases Pharmacists. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists",
        "Use of Monte Carlo simulation and considerations for PK-PD targets to support antibacterial dose selection",
        "Extended-interval dosing of aminoglycoside antibiotics in critically ill patients",
        "Animal model pharmacokinetics and pharmacodynamics: a critical review",
        "Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria",
        "Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis",
        "Canadian Antimicrobial Resistance Alliance. Integrating pharmacokinetics, pharmacodynamics and MIC distributions to assess changing antimicrobial activity against clinical isolates of Pseudomonas aeruginosa causing infections in Canadian hospitals (CANWARD)",
        "What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review",
        "Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose",
        "Suboptimal aminoglycoside dosing in critically ill patients",
        "Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring",
        "Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units",
        "Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis",
        "An international survey on aminoglycoside practices in critically ill patients: the AMINO III study",
        "Pharmacokinetic/pharmacodynamic-guided gentamicin dosing in critically ill patients: a revisit of the Hartford nomogram",
        "EAST practice management guidelines work group: update to practice management guidelines for prophylactic antibiotic use in open fractures",
        "Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy",
        "Optimization of aminoglycoside therapy",
        "Experience with a once-daily aminoglycoside program administered to 2184 adult patients",
        "Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity",
        "Clinical practice guidelines for antimicrobial prophylaxis in surgery",
        "Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022182",
            "affilname": "Siam University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022182",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "TEH-AC",
        "Faculty of Pharmaceutical Sciences",
        "Prince of Songkla University"
    ]
}